NovaBay Pharmaceuticals (NBY) has had the highest return since 2025 by a small-cap US stock, returning 1,346.2%.
| ASSET | % RETURN |
|---|---|
NovaBay Pharmaceuticals (NBY) | 1,346.15% |
Hycroft Mining (HYMC) | 951.77% |
Zepp Health (ZEPP) | 936.15% |
Relmada Therapeutics (RLMD) | 830.99% |
Palvella Therapeutics (PVLA) | 801.55% |
Diginex Limited Ordinary Shares (DGNX) | 683.1% |
DeFi Development (DFDV) | 650.48% |
Nanobiotix (NBTX) | 643.41% |
AXT (AXTI) | 636.49% |
Avino Silver & Gold Mines (ASM) | 582.42% |
Newegg Commerce (NEGG) | 534.5% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 515.33% |
Almonty Industries Inc Common Shares (ALM) | 511.81% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | 501.03% |
DBV Technologies (DBVT) | 482.67% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 471.67% |
Americas Silver (USAS) | 437.89% |
Invivyd (IVVD) | 425.53% |
Inhibrx Biosciences (INBX) | 416% |
Nutex Health (NUTX) | 413.96% |
IsoEnergy (ISOU) | 386.63% |
Village Farms International (VFF) | 370.36% |
I-Mab (IMAB) | 368.24% |
Integra Resources (ITRG) | 355.68% |
ThredUp (TDUP) | 343.75% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
